Survival of Medicare patients after enrollment in hospice programs

被引:368
作者
Christakis, NA
Escarce, JJ
机构
[1] UNIV CHICAGO, DEPT SOCIOL, CHICAGO, IL 60637 USA
[2] UNIV PENN, DEPT MED, DIV GEN INTERNAL MED, PHILADELPHIA, PA 19104 USA
[3] UNIV PENN, LEONARD DAVIS INST HLTH ECON, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1056/NEJM199607183350306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Each year more than 220,000 Medicare beneficiaries receive care from hospice programs designed to enhance the quality of the end of life. Enrollment requires certification by a physician that the patient has a life expectancy of less than six months. We examined how long before death patients enrolled in hospice programs. Methods Using 1990 Medicare claims data, we analyzed the characteristics and survival of 6451 hospice patients followed for a minimum of 27 months with respect to mortality. Results The patients' mean age was 76.4 years; 92.4 percent were white, Half the patients were women, and 80.2 percent had cancer of some type. The most common diagnoses were lung cancer (21.4 percent), colorectal cancer (10.5 percent), and prostate cancer (7.4 percent). The median survival after enrollment was only 36 days, and 15.6 percent of the patients died within 7 days. At the other extreme, 14.9 percent of the patients lived longer than six months. Survival varied substantially according to diagnosis, even after adjustment for age and coexisting conditions. The unadjusted survival after enrollment was shortest for those with renal failure, those with leukemia or lymphoma, and those with liver or biliary cancer; it was longest for those with chronic lung disease, those with dementia, and those with breast cancer. Patients at for-profit, larger, outpatient, or newer hospices lived longer after enrollment than those in other types of hospice programs. Conclusions Most patients who enter hospice care do so late in the course of their terminal illnesses, The timing of enrollment in hospice programs varies substantially with the characteristics of the patients and the hospices. (C) 1996, Massachusetts Medical Society.
引用
收藏
页码:172 / 178
页数:7
相关论文
共 44 条
  • [1] FACTORS ASSOCIATED WITH LENGTH OF SURVIVAL AMONG 1081 TERMINALLY ILL CANCER-PATIENTS
    ALLARD, P
    DIONNE, A
    POTVIN, D
    [J]. JOURNAL OF PALLIATIVE CARE, 1995, 11 (03) : 20 - 24
  • [2] BRODY H, 1984, NEW ENGL J MED, V310, P920
  • [3] HOSPICE HOME CARE COST SAVINGS TO 3RD-PARTY INSURERS
    BROOKS, CH
    SMYTHSTARUCH, K
    [J]. MEDICAL CARE, 1984, 22 (08) : 691 - 703
  • [4] ESTIMATE OF SURVIVAL OF PATIENTS ADMITTED TO A PALLIATIVE CARE UNIT - A PROSPECTIVE-STUDY
    BRUERA, E
    MILLER, MJ
    KUEHN, N
    MACEACHERN, T
    HANSON, J
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (02) : 82 - 86
  • [5] RX FOR DYING - THE CASE FOR HOSPICE
    BULKIN, W
    LUKASHOK, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (06) : 376 - 378
  • [6] Carney K, 1989, Nurs Econ, V7, P41
  • [7] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [8] TIMING OF REFERRAL OF TERMINALLY ILL PATIENTS TO AN OUTPATIENT HOSPICE
    CHRISTAKIS, NA
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1994, 9 (06) : 314 - 320
  • [9] Cohen J, 1984, APPL MULTIPLE REGRES, V2, P183
  • [10] Davis F A, 1988, Health Care Financ Rev, V9, P99